Swiss Cancer Institute

This study is for men with advanced prostate cancer that has spread and stopped responding to standard hormone treatments. Researchers want to see if adding a drug called darolutamide to the usual first-choice treatments (like chemotherapy) can better control the cancer and delay…

This study is testing if adding a common antibiotic called doxycycline to standard chemotherapy can improve treatment for early-stage breast cancer. The goal is to see if doxycycline can target stubborn 'cancer stem cells' that are thought to survive chemo and cause the cancer to…

This trial is testing whether a new combination treatment approach is practical for patients with high-risk soft tissue sarcomas. It combines chemotherapy with targeted heat therapy, followed by radiation and surgery, to try to improve survival. The study will enroll 24 patients …

This study is testing whether a new liquid biopsy method can better detect when aggressive B-cell lymphoma has spread to the brain and spinal cord. Researchers will compare this new test, which looks for tumor DNA in spinal fluid, against current standard diagnostic methods. The …